Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Skyhawk Therapeutics logo — We Use Small Molecules To Modify RNA Splicing

Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing

Founded 2016 United States Waltham, United States 93 employees Total: $181.20M Biotechnology, Health and Wellness

General Information

Company Name Skyhawk Therapeutics
Founded Year 2016
Location United States Waltham, United States
Employees 93
Industries Biotechnology, Health and Wellness
Business Model B2B, Platform
Revenue Model Licensing, Performance Based, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Skyhawk Therapeutics. To contact Skyhawk Therapeutics, visit skyhawktx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Skyhawk Therapeutics compare?

A PDF of Skyhawk Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Skyhawk Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Skyhawk Therapeutics

Skyhawk Therapeutics, founded in 2016, is at the forefront of drug discovery and development within the Biotechnology and Health and Wellness industries. Stationed in Waltham, Massachusetts, this innovative company is pioneering the treatment of diseases with small molecules designed to modify RNA splicing.

Underpinned by a team of leading experts in small molecule therapeutics, Skyhawk Therapeutics is focusing its efforts on drug candidates that target cancers and neurological conditions. Its mission of revolutionizing disease treatment is encapsulated in their slogan: "We Use Small Molecules To Modify RNA Splicing."

The company's most recent funding event saw a substantial injection of $133.00M in a Venture Round on 14 September 2021, with notable participation from Fidelity. This robust support underscores confidence in Skyhawk's potential to make significant strides in disease treatment innovations.

Business keywords: Small Molecule Therapeutics, RNA Splicing Modification, Drug Discovery, RNA-based Disease Treatment, Cancer Therapeutics, Neurological Condition Treatments, Proprietary Technology, Therapeutics Development, Exon Skipping, RNA Expression Correction, Binding Pocket Targeting, Sequence Specificity, Structural Specificity, Waltham-based

Services & Products

Development of RNA-targeting small molecules
Conducting clinical trials
Collaborative drug development with pharma companies
Expanding internal pipeline for neurology, oncology, and fibrotic diseases

Target Customers

Patients with Huntington's Disease Pharmaceutical Companies Biotechnology Researchers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC $133.00M 1
Fidelity Investments
01 Sep 2021
Series A Undisclosed 1
Good Growth Capital
Good Growth Capital
01 Jan 2019
Early VC $40.00M 4
GreatPoint Ventures Agent Capital Alexandria Venture Investments
GreatPoint Ventures, Agent Capital +2
01 Jun 2018
Seed $8.00M 3
Alexandria Venture Investments Bedford Capital
Alexandria Venture Investments, Bedford Capital +1
01 Jan 2018
Convertible Note $200.00K 1
Good Growth Capital
Good Growth Capital
01 Feb 2017

Skyhawk Therapeutics Alternatives & Competitors

View All Alternatives
Skyhawk Therapeutics vs
Nimbus Therapeutics
Nimbus Therapeutics United States

We develop breakthrough medicines for patients through precision small molecule design.

103 employees
Biotechnology, Health Care
Compare Skyhawk Therapeutics vs Nimbus Therapeutics
Skyhawk Therapeutics vs
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. United States

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
Compare Skyhawk Therapeutics vs TransCode Therapeutics, Inc.
Skyhawk Therapeutics vs
1910 Genetics
1910 Genetics United States

Advancing small and large molecule drug discovery with a multimodal AI platform powered by laborator...

Venture round
37 employees
AI, Biotechnology
Also compare with: Skyhawk Therapeutics vs Rgenta Therapeutics Inc. Rgenta Therapeutics Inc. Skyhawk Therapeutics vs Atavistik Bio Atavistik Bio Skyhawk Therapeutics vs CAMP4 Therapeutics CAMP4 Therapeutics View all alternatives

FAQ About Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing
Skyhawk Therapeutics was founded in 2016.
Skyhawk Therapeutics is headquartered in Waltham, United States.
Skyhawk Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on Small Molecule Therapeutics, RNA Splicing Modification, Drug Discovery and RNA-based Disease Treatment. Its customers include Patients with Huntington's Disease, Pharmaceutical Companies and Biotechnology Researchers.
Skyhawk Therapeutics has a B2B and Platform business model. Its revenue comes from Licensing, Performance Based and Project Based.
Skyhawk Therapeutics has approximately 93 employees.
Skyhawk Therapeutics has completed 5 funding rounds, raising a total of $181.20M.
Skyhawk Therapeutics offers: Development of RNA-targeting small molecules, Conducting clinical trials, Collaborative drug development with pharma companies, Expanding internal pipeline for neurology, oncology, and fibrotic diseases.
Top alternatives and competitors to Skyhawk Therapeutics include Nimbus Therapeutics, TransCode Therapeutics, Inc., 1910 Genetics, Rgenta Therapeutics Inc., Atavistik Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Skyhawk Therapeutics and Nimbus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Skyhawk Therapeutics, https://bouncewatch.com/company/skyhawk-therapeutics, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout